Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000619788 | SCV000736546 | likely benign | Cardiovascular phenotype | 2016-02-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000630591 | SCV000751556 | benign | Duchenne muscular dystrophy | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000732266 | SCV000860191 | likely benign | not specified | 2018-03-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001683611 | SCV001903510 | benign | not provided | 2020-04-24 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000732266 | SCV005039458 | benign | not specified | 2024-03-12 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001834966 | SCV002077578 | likely benign | Becker muscular dystrophy; Duchenne muscular dystrophy; Cardiomyopathy; Dystrophin deficiency | 2020-07-30 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004533273 | SCV004713478 | likely benign | DMD-related disorder | 2023-06-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |